Clinical Trials Logo
  1. Home
  2. Intestinal Disease
  3. NCT05249335

Comparison for Efficacy and Safety of Bowel Preparation Between Oral Sulfate Table and 2L-polyethylene Glycol/Ascorbate in Elderly

Intestinal Disease Clinical Trial

Official title:
Comparison for Efficacy and Safety of Bowel Preparation Between Oral Sulfate Table and 2L-polyethylene Glycol/Ascorbate in Elderly: Multicenter, Prospective, Investigator Single-blinded, Randomized Study

Clinical Trial Summary

This study compares the effectiveness and stability of intestinal tablet (OST), an oral sulfate table (OST), developed in the form of pills, with 2L-PEG/Asc for examinees aged 70 or older who are scheduled for colonoscopy.

Clinical Trial Description

This study is comparison for efficacy and safety of bowel preparation between oral sulfate table and 2L-polyethylene glycol/ascorbate in elderly: multicenter, prospective, investigator single-blinded, randomized study. A total of 256 subjects will participate to this study and be assigned to the test group or the control group. The subject will administer the first dose of assigned investigational product in the evening prior to the scheduled colonoscopy. Subject will take the second dose early in the morning of the colonoscopy. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT05249335
Study type Interventional
Source Pharmbio Korea Co., Ltd.
Contact Cha Jaemyeong, M.D, Ph.D
Phone +82-2-440-6113
Email clicknox@hanmail.net
Status Not yet recruiting
Phase Phase 4
Start date February 2022
Completion date February 2024
View Details
See also
  Status Clinical Trial Phase
Active, not recruiting NCT05551052 - CRC Detection Reliable Assessment With Blood
Recruiting NCT05194527 - The Detrimental Course of Acute Intestinal Ischemia
Recruiting NCT04605627 - The Role of Gut Leakage Markers and Microbiota Signature in Coronary Artery Disease.
Enrolling by invitation NCT04502784 - Investigation of Hypophosphataemia Following Intravenous Iron
Completed NCT03559543 - Evaluation of Ocoxin®-Viusid® in Metastatic Colorectal Adenocarcinoma Phase 2
Completed NCT03723447 - Intraoperative TAP Block With Bupivacaine/Dexamethasone Against Liposomal Bupivacaine (Exparel®) Phase 4
Completed NCT04573959 - Validation of CapsoVision CapsoCam® SV-3 Capsule Endoscopy System N/A
Active, not recruiting NCT01236833 - Lactated Ringer's Solution in Neonates With Feeding Intolerance Phase 2
Not yet recruiting NCT04123990 - Study of the Prevalence of Iron Deficiency in Patients With Chronic Inflammatory Bowel Disease N/A
Not yet recruiting NCT06271538 - Evaluation of Efficacy of Skål Pro Powder on Symptoms of Irritable Bowel Syndrome Phase 4
Completed NCT02785783 - Endorings™ Assisted Colonoscopy Versus Standard Colonoscopy for Polyp Detection N/A
Completed NCT03012594 - Lanreotide in the Treatment of Small Bowel Motility Disorders Phase 2
Recruiting NCT06007313 - Mental Stress and Bowel Preparation Quality
Completed NCT04982302 - Gut Microbial Changes After Periodontal Treatment
Completed NCT03543540 - Bioequivalence Study of Nexvax2 in Subjects With Celiac Disease Phase 1
Completed NCT03817645 - Panaceo "MED" for IBS (Irritable Bowel Syndrome) N/A
Completed NCT00072943 - A Humanized Anti-Interferon-γ Monoclonal Antibody (HuZAF) for Moderate to Severe Crohn's Disease Phase 2
Completed NCT03037385 - Phase 1/2 Study of the Highly-selective RET Inhibitor, Pralsetinib (BLU-667), in Participants With Thyroid Cancer, Non-Small Cell Lung Cancer, and Other Advanced Solid Tumors Phase 1/Phase 2
Recruiting NCT03280407 - NEOadjuvant Chemotherapy Only Compared With Standard Treatment for Locally Advanced Rectal Cancer Phase 2
Completed NCT04263818 - Endoscopist and Endoscope Motions During Colonoscopy N/A